These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9169946)

  • 21. Composite grafts of autogenic cultured epidermis and glycerol-preserved allogeneic dermis for definitive coverage of full thickness burn wounds: case reports.
    Schiozer WA; Hartinger A; von Donnersmarck GH; Mühlbauer W
    Burns; 1994 Dec; 20(6):503-7. PubMed ID: 7880414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postal survey on the use of glycerol-preserved allografts in clinical practice.
    Mackie D
    Burns; 2002 Oct; 28 Suppl 1():S40-4. PubMed ID: 12237064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns.
    Hermans MH
    Burns Incl Therm Inj; 1989 Feb; 15(1):57-9. PubMed ID: 2655834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing.
    Maral T; Borman H; Arslan H; Demirhan B; Akinbingol G; Haberal M
    Burns; 1999 Nov; 25(7):625-35. PubMed ID: 10563689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunogenicity of glycerol-preserved donor skin.
    Hettich R; Ghofrani A; Hafemann B
    Burns; 1994; 20 Suppl 1():S71-5; discussion S75-6. PubMed ID: 8198749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstruction of human skin from glycerol-preserved allodermis and cultured keratinocyte sheets.
    McKay I; Woodward B; Wood K; Navsaria HA; Hoekstra H; Green C
    Burns; 1994; 20 Suppl 1():S19-22. PubMed ID: 8198736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts.
    Saegeman VS; Ectors NL; Lismont D; Verduyckt B; Verhaegen J
    Burns; 2008 Mar; 34(2):205-11. PubMed ID: 18037568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cologne Burn Centre experiences with glycerol-preserved allogeneic skin: Part I: Clinical experiences and histological findings (overgraft and sandwich technique).
    Horch R; Stark GB; Kopp J; Spilker G
    Burns; 1994; 20 Suppl 1():S23-6. PubMed ID: 8198737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of variation of cryopreservation protocols on the immunogenicity of allogeneic skin grafts.
    Ingham E; Matthews JB; Kearney JN; Gowland G
    Cryobiology; 1993 Oct; 30(5):443-58. PubMed ID: 8252912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycerolised allogenic skin: transplant or dressing? A medico-legal question.
    Burd A
    Burns; 2002 Oct; 28 Suppl 1():S34-9. PubMed ID: 12237063
    [No Abstract]   [Full Text] [Related]  

  • 32. Maintaining a glycerolized skin bank--a practical approach.
    Vuola J; Pipping D
    Burns; 2002 Oct; 28 Suppl 1():S31-3. PubMed ID: 12237062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the use of glycerol preserved and cryopreserved allogenic skin for the treatment of severe burns: differences in clinical outcomes and in vitro tissue viability.
    Kua EH; Goh CQ; Ting Y; Chua A; Song C
    Cell Tissue Bank; 2012 Jun; 13(2):269-79. PubMed ID: 21484230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis of Ia antigen-bearing keratinocytes: mixed skin lymphocyte culture between Ia antigen-bearing Pam 212 cells and allogeneic and syngeneic splenic T cells.
    Aiba S; Tagami H
    J Invest Dermatol; 1987 Dec; 89(6):560-6. PubMed ID: 3119731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glycerol on intracellular virus survival: implications for the clinical use of glycerol-preserved cadaver skin.
    Marshall L; Ghosh MM; Boyce SG; MacNeil S; Freedlander E; Kudesia G
    Burns; 1995 Aug; 21(5):356-61. PubMed ID: 7546258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximizing the safety of glycerol preserved human amniotic membrane as a biological dressing.
    Zidan SM; Eleowa SA; Nasef MA; Abd-Almoktader MA; Elbatawy AM; Borhamy AG; Aboliela MA; Ali AM; Algamal MR
    Burns; 2015 Nov; 41(7):1498-503. PubMed ID: 26188890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilisation of glycerolised skin allografts in severe burns.
    Dhennin Ch; Desbois I; Yassine A; Benissad H; Lignée J
    Burns; 2002 Oct; 28 Suppl 1():S21-5. PubMed ID: 12237060
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomised clinical trial comparing a hydrocolloid-derived dressing and glycerol preserved allograft skin in the management of partial thickness burns.
    Vloemans AF; Soesman AM; Suijker M; Kreis RW; Middelkoop E
    Burns; 2003 Nov; 29(7):702-10. PubMed ID: 14556729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds.
    Hansbrough JF; Mozingo DW; Kealey GP; Davis M; Gidner A; Gentzkow GD
    J Burn Care Rehabil; 1997; 18(1 Pt 1):43-51. PubMed ID: 9063787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of glycerolized cadaver skin for the treatment of scalds in children.
    Peeters R; De Caluwe D; Neetens C; Hubens A
    Burns; 1994; 20 Suppl 1():S32-3. PubMed ID: 8198739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.